Although the U.S. is still the leading country behind biotech innovation, China is close behind, according to a Johnson & Johnson (NYSE:JNJ) business development executive. Nauman Shah, global head of ...

The fund aims to build a portfolio of 20-25 companies that address gaps in services and products across pharmaceuticals, ...

A joint report by the Institute for Deep Tech Innovation (DEEP) at ESMT Berlin and the Bertelsmann Stiftung highlights Germany’s immense innovation potential in the biotech sector. However, this ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

Biotech Showcase™ 2025 Opens the Year with ... These vital one-to-one engagements are the wellspring of deals that drive innovation in our industry. Plus, tired of market noise?

Biotech Showcase™ 2025 Opens the Year with More than 3,000 Attendees, 340+ Presenting Companies, 1,020+ Investors and 85+ Members of the Media ...

has highlighted the Guidelines’ risks to biotech innovation and commercialization: [T]he NIH [G]uidelines allow the bureaucracy to second-guess purely business decisions like how a resulting ...